These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 32280688)
1. Identification of Circulating MicroRNAs as a Promising Diagnostic Biomarker for Cervical Intraepithelial Neoplasia and Early Cancer: A Meta-Analysis. Jiang Y; Hu Z; Zuo Z; Li Y; Pu F; Wang B; Tang Y; Guo Y; Tao H Biomed Res Int; 2020; 2020():4947381. PubMed ID: 32280688 [TBL] [Abstract][Full Text] [Related]
2. Circulating micrornas as potential diagnostic biomarkers for cervical intraepithelial neoplasia and cervical cancer: a systematic review and meta-analysis. Li Y; Zhu L; Zhu C; Chen Y; Yu H; Zhu H; Yin P; Liu M; Li Y; Li H; Gong Z; Hanzi Xu ; Han J Discov Oncol; 2024 May; 15(1):189. PubMed ID: 38801504 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of circulating microRNAs for osteosarcoma in Asian populations: a meta-analysis. Wang X; Ning Y; Yang L; Liu H; Wu C; Wang S; Guo X Clin Exp Med; 2017 May; 17(2):175-183. PubMed ID: 27106278 [TBL] [Abstract][Full Text] [Related]
4. Exosomal let-7d-3p and miR-30d-5p as diagnostic biomarkers for non-invasive screening of cervical cancer and its precursors. Zheng M; Hou L; Ma Y; Zhou L; Wang F; Cheng B; Wang W; Lu B; Liu P; Lu W; Lu Y Mol Cancer; 2019 Apr; 18(1):76. PubMed ID: 30940131 [TBL] [Abstract][Full Text] [Related]
5. The Potential Diagnostic Accuracy of Circulating MicroRNAs for Leukemia: A Meta-Analysis. Zhang WT; Zhang GX; Gao SS Technol Cancer Res Treat; 2021; 20():15330338211011958. PubMed ID: 33902358 [TBL] [Abstract][Full Text] [Related]
6. The potential of circulating microRNAs as novel diagnostic biomarkers of COVID-19: a systematic review and meta-analysis. Belete MA; Anley DT; Tsega SS; Moges N; Anteneh RM; Zemene MA; Gebeyehu AA; Dessie AM; Kebede N; Chanie ES; Alemayehu E BMC Infect Dis; 2024 Sep; 24(1):1011. PubMed ID: 39300343 [TBL] [Abstract][Full Text] [Related]
7. Cytology versus HPV testing for cervical cancer screening in the general population. Koliopoulos G; Nyaga VN; Santesso N; Bryant A; Martin-Hirsch PP; Mustafa RA; Schünemann H; Paraskevaidis E; Arbyn M Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008587. PubMed ID: 28796882 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of circulating microRNAs for esophageal cancer: a meta-analysis based on Asian data. Zhang WT; Wang YJ; Zhang GX; Zhang YH; Gao SS Rev Esp Enferm Dig; 2023 Sep; 115(9):504-514. PubMed ID: 35040334 [TBL] [Abstract][Full Text] [Related]
9. Gastric Cancer and Circulating microRNAs: An Updated Systematic Review and Diagnostic Meta-Analysis. Aalami AH; Aalami F; Sahebkar A Curr Med Chem; 2023; 30(33):3798-3814. PubMed ID: 36411580 [TBL] [Abstract][Full Text] [Related]
10. A panel of circulating miRNAs as diagnostic biomarkers for screening multiple myeloma: a systematic review and meta-analysis. Zhang L; Cao D; Tang L; Sun C; Hu Y Int J Lab Hematol; 2016 Dec; 38(6):589-599. PubMed ID: 27870469 [TBL] [Abstract][Full Text] [Related]
11. Circulating microRNAs as diagnostic biomarkers for melanoma: a systematic review and meta-analysis. Wu N; Sun H; Sun Q; Zhang F; Ma L; Hu Y; Cong X BMC Cancer; 2023 May; 23(1):414. PubMed ID: 37158840 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of circulating microRNAs in thyroid carcinoma: A systematic review and meta-analysis. Xu SL; Tian YY; Zhou Y; Liu LQ Clin Endocrinol (Oxf); 2020 Oct; 93(4):489-498. PubMed ID: 32379941 [TBL] [Abstract][Full Text] [Related]
13. Circulating microRNAs as Potential Biomarkers for the Diagnosis of Endometrial Cancer: a Meta-Analysis. Gao J; Fan YZ; Gao SS; Zhang WT Reprod Sci; 2023 Feb; 30(2):464-472. PubMed ID: 35764858 [TBL] [Abstract][Full Text] [Related]
14. The potential diagnostic accuracy of circulating microRNAs for prostate cancer: A meta-analysis. Zhang WT; Zhang GX; Zhao RZ; Gao SS Actas Urol Esp (Engl Ed); 2022 Apr; 46(3):138-149. PubMed ID: 35260368 [TBL] [Abstract][Full Text] [Related]
15. Exosomal miRNAs as Biomarkers of Cancer: a Meta-Analysis. Yang B; Xiong WY; Hou HJ; Xu Q; Cai XL; Zeng TX; Ha XQ Clin Lab; 2019 May; 65(5):. PubMed ID: 31115208 [TBL] [Abstract][Full Text] [Related]
16. A systematic review and meta-analysis of miRNAs for the detection of cervical cancer. Hillyar CR; Kanabar SS; Pufal KR; Saw Hee JL; Lawson AW; Mohamed Y; Jasim D; Reed L; Rallis KS; Nibber A Epigenomics; 2023 May; 15(10):593-613. PubMed ID: 37535320 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic Value of Serum hsa-mir-92a in Patients with Cervical Cancer. Kong Q; Tang Z; Xiang F; Jiang J; Yue H; Wu R; Kang X Clin Lab; 2017 Feb; 63(2):335-340. PubMed ID: 28182350 [TBL] [Abstract][Full Text] [Related]
18. Circulating microRNA-21 as a biomarker for the detection of various carcinomas: an updated meta-analysis based on 36 studies. Wu K; Li L; Li S Tumour Biol; 2015 Mar; 36(3):1973-81. PubMed ID: 25527152 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA Biomarkers of High-Grade Cervical Intraepithelial Neoplasia in Liquid Biopsy. Causin RL; da Silva LS; Evangelista AF; Leal LF; Souza KCB; Pessôa-Pereira D; Matsushita GM; Reis RM; Fregnani JHTG; Marques MMC Biomed Res Int; 2021; 2021():6650966. PubMed ID: 33954190 [TBL] [Abstract][Full Text] [Related]
20. Blood-based microRNAs as Potential Diagnostic Biomarkers for Melanoma: A Meta-Analysis. Aalami A; Abdeahad H; Mokhtari A; Aalami F; Amirabadi A; Aliabadi EK; Pirzade O; Sahebkar A Curr Med Chem; 2024; 31(31):5083-5096. PubMed ID: 37165504 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]